最新消息

SINGAPORE: HSA ATTAINS HIGHEST LEVEL RECOGNITION FROM WHO FOR MEDICAL DEVICE REGULATORY SYSTEM – March/April 2026

SINGAPORE: HSA ATTAINS HIGHEST LEVEL RECOGNITION FROM WHO FOR MEDICAL DEVICE REGULATORY SYSTEM – March/April 2026

  • 2026-04-23 09:11:50

Singapore's Health Sciences Authority (HSA) has achieved the World Health Organization (WHO) Maturity Level 4 for medical device regulatory systems, the highest classification under WHO's global benchmarking framework. The recognition, announced on 10 March 2026 during the International Medical Device Regulators Forum (IMDRF) 29th session in Singapore, strengthens Singapore's position in global medical device regulation as a trusted reference authority for other regulators.

了解更多
Japan: Rising Need for Orthopedic Medical Devices – March/April 2026

Japan: Rising Need for Orthopedic Medical Devices – March/April 2026

  • 2026-04-23 08:41:55

Japan's orthopedic medical device market is drawing increasing global attention, supported by strong import activity and rising clinical demand. In 2023, orthopedic equipment accounted for the largest share of Japan's medical device imports at 14.9%, while orthopedic appliances alone reached US$2.67B in imports in 2024. With nearly 30% of the population aged 65 and above and more than 3.4M orthopedic procedures performed annually, Japan continues to see growing demand for advanced musculoskeletal solutions.

了解更多
QT Activity: Webinar Recap | Medical Device Studies in the US: Regulatory Requirements, Study Design, and Best Practices in Subject Management – March/April 2026

QT Activity: Webinar Recap | Medical Device Studies in the US: Regulatory Requirements, Study Design, and Best Practices in Subject Management – March/April 2026

  • 2026-04-23 07:36:58

The webinar hosted by Qualtech in March takes a closer look at how medical device studies are conducted in the United States. Covering US FDA classification, IDE and IRB pathways, and study design, it connects regulatory frameworks with their practical application in study execution. This recap highlights key considerations shaping how studies are structured and managed in the US context.

了解更多
Vietnam: Regulatory Update on Goods Labeling under Decree No. 37/2026/ND-CP – February/March 2026

Vietnam: Regulatory Update on Goods Labeling under Decree No. 37/2026/ND-CP – February/March 2026

  • 2026-04-02 02:37:23

Decree No. 37/2026/ND-CP introduces updated labeling requirements in Vietnam, replacing previous regulations. It strengthens and supplements the rules on mandatory label information, while also introducing additional provisions on electronic labeling and specific requirements for medical devices. Transitional provisions are included to support the continued use of previously compliant labels for a limited period.

了解更多
SINGAPORE: HSA responds to consultation on proposed AI-SaMD licensing and registration exemption for selected public healthcare entities – February/March 2026

SINGAPORE: HSA responds to consultation on proposed AI-SaMD licensing and registration exemption for selected public healthcare entities – February/March 2026

  • 2026-04-02 01:20:01

Health Sciences Authority (HSA) has responded to feedback from its public consultation on a proposed regulatory sandbox that exempts selected low‑risk artificial intelligence software as a medical device (AI‑SaMD) from manufacturer licensing and product registration requirements under controlled conditions. The sandbox aims to balance regulatory oversight and innovation by allowing public healthcare institutions to develop and deploy AI tools for non‑critical medical conditions while collecting real‑world insights to inform future regulatory frameworks.

了解更多
Philippines: An Overview of the Proposed PFDA Guidelines for Medical Device Surveillance and Traceability – February/March 2026

Philippines: An Overview of the Proposed PFDA Guidelines for Medical Device Surveillance and Traceability – February/March 2026

  • 2026-04-01 09:14:49

The proposed PFDA guidelines establish requirements for maintaining importation and distribution records and for reporting product complaints, adverse events, and field safety corrective actions for medical devices to ensure traceability and facilitate appropriate regulatory action. This article outlines the specific responsibilities, strict reporting timelines, and record-keeping mandates designed to protect public health throughout the device lifecycle.

了解更多
Qualech Webinar: From Paperwork to Practice – Mastering EU MDR Technical Documentation – April 2026

Qualech Webinar: From Paperwork to Practice – Mastering EU MDR Technical Documentation – April 2026

  • 2026-04-01 07:49:34

Qualtech invites you to a free webinar on April 17, 2026, on mastering Technical Documentation under the EU Medical Device Regulation (MDR). Regulatory expert Dr. Arkan Zwick will share practical guidance on MDR documentation, Annex XVI requirements, legacy device transitions, and working with notified bodies. The session provides valuable insights for all medical device manufacturers currently active in, or planning to enter, the European market.

了解更多
MALAYSIA: MDA Regulatory Updates – Requirement of Labelling Guidance Document & HSA Verification Approvals – February/March 2026

MALAYSIA: MDA Regulatory Updates – Requirement of Labelling Guidance Document & HSA Verification Approvals – February/March 2026

  • 2026-04-01 07:01:44

The Medical Device Authority (MDA), Malaysia, announces two key updates for medical device registration. The latest labelling guidance introduces e-labelling requirements, while conformity assessments conducted by Singapore's Health Sciences Authority (HSA) are now recognized through a verification-based process. These updates aim to streamline registration and ensure compliance for medical devices in Malaysia.

了解更多